drugset / Trial / NCT00128154
Chromium Picolinate for the Treatment of Metabolic Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether chromium supplements can reduce symptoms of metabolic syndrome, a collection of symptoms that increase one's risk for developing heart disease, stroke, and diabetes.
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chromium Picolinate | Other / unclassified | 1000 ug | — |